Riskpilot← Back to searchSign inGet full accessCBG Labs AB
ABActiveOrg 5592419948Östgötagatan 12Business and other management consultancy activities · NACE 7020Est. 20201-4 employees
Revenue 2024
SEK 1,7M
-15% vs 2023
EBITDA margin
36.3%
-30% vs 2023
Equity ratio
92.5%
Financial strength
Net profit 2024
SEK 553K
-18% vs 2023
| Revenue | SEK 1,7M | -15% |
| EBITDA | SEK 600K | -30% |
| Net profit | SEK 553K | -18% |
| Total assets | SEK 2,1M | +25% |
| Equity | SEK 1,9M | +40% |
| Employees | — | — |
Legal name
CBG Labs AB
Org number
5592419948
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
12 februari 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla konsulttjänster och coaching inom marknadsföring, organisation, IT och ledarskap. Bolaget kommer även bedriva försäljning av internetbaserade informations- produkter såsom e-böcker och onlineutbildningar, digitala tjänster samt bedriva handel med värdepapper, samt därmed förenlig verksamhet.
Address
Östgötagatan 12
Email
cecilia@cbgl.co
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 559 | 1 553 | 1 865 | 1 941 | 1 651 |
| Staff expenses | — | — | −783 | −764 | −800 |
| EBITDA | 278 | 679 | 848 | 852 | 600 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 278 | 679 | 848 | 852 | 600 |
| Net financials | — | — | −1 | −4 | 131 |
| Profit before tax | 277 | 679 | 847 | 848 | 731 |
| Tax | −59 | −140 | −177 | −177 | −179 |
| Net profit | 218 | 539 | 671 | 671 | 553 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 456 | 1 473 | 1 405 | 1 684 | 2 101 |
| Equity | 243 | 782 | 1 005 | 1 391 | 1 944 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 212 | 691 | 400 | 293 | 157 |
| Total debt | 212 | 691 | 400 | 293 | 157 |
EBITDA margin
36.3%
This company
15.8%
Market median
+130% vs market
20202024
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
20202024
Net profit margin
33.5%
This company
8.1%
Market median
+314% vs market
20202024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CBG Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christina Louise Kolmodin | Deputy Board Member | 0 companies |
| Anna Cecilia Bratt | Board of Directors | 0 companies |